Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00916669 | A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 1 | May 8, 2013 | clinicaltrials |
| NCT00606970 | Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy | withdrawn | Early Phase 1 | 0 | New Hope Medical CenterNETWORK | 0 | May 7, 2013 |
| clinicaltrials |
| NCT00043212 | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. | withdrawn | Phase 3 | 0 | Northwest BiotherapeuticsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT01781442 | A Post Marketing Surveillance As Required By Philippine Food And Drug Administration | withdrawn | — | 0 | PfizerINDUSTRY | 0 | May 1, 2013 | clinicaltrials |
| NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT00903214 | Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT00691977 | Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate | withdrawn | Phase 1 | 0 | Virginia Commonwealth UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00268255 | Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 16, 2013 | clinicaltrials |
| NCT00960427 | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 16, 2013 | clinicaltrials |
| NCT00968461 | Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 15, 2013 | clinicaltrials |
| NCT00873808 | S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 | withdrawn | — | 0 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00899002 | Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer | withdrawn | — | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 10, 2013 | clinicaltrials |
| NCT01432119 | Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 9, 2013 | clinicaltrials |
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | withdrawn | Phase 3 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT01616186 | Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) | withdrawn | Phase 2 | 0 | Andrea HarzstarkOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT00968396 | Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT01340729 | Open-Label Study of TPI 287 for Patients With Metastatic Melanoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01427205 | Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT01508260 | Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT00253617 | Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 2 | Apr 4, 2013 | clinicaltrials |
| NCT00499668 | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer | withdrawn | N/A | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT00601991 | A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia | withdrawn | Phase 2 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT01007422 | Opioids Titration in Hospice Patients | withdrawn | — | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT01480141 | A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 2 | 0 | Medical University of South CarolinaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00025051 | Celecoxib in Preventing Skin Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00030355 | Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Mar 22, 2013 | clinicaltrials |
| NCT01786538 | Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines | withdrawn | Phase 3 | 0 | Asan Medical CenterOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00003435 | Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT01416844 | Study of Immune Responses in Patients With Metastatic Melanoma | withdrawn | Phase 2 | 0 | Providence Health & ServicesOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT01478308 | Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | New Mexico Cancer Research AllianceOTHER | 0 | Mar 6, 2013 | clinicaltrials |
| NCT00601120 | RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma | withdrawn | N/A | 0 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 27, 2013 | clinicaltrials |
| NCT01401387 | Pancreatic Enzyme Suppletion in Pancreatic Cancer(EPC) | withdrawn | Phase 4 | 0 | Foundation for Liver ResearchOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00311545 | S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Feb 20, 2013 | clinicaltrials |
| NCT01680796 | Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma | withdrawn | Phase 1 | 0 | University of FloridaOTHER | 0 | Feb 20, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT01612728 | Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer(AIA) | withdrawn | Phase 2 | 0 | Baylor Breast Care CenterOTHER | 0 | Feb 12, 2013 | clinicaltrials |
| NCT01553123 | Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma | withdrawn | Phase 3 | 0 | Watson PharmaceuticalsINDUSTRY | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00524069 | Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 1, 2013 | clinicaltrials |
| NCT00559481 | Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 1, 2013 | clinicaltrials |
| NCT00903305 | Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Feb 1, 2013 | clinicaltrials |
| NCT01216787 | RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00090675 | Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer(IMAC/Herbst) | withdrawn | Phase 3 | 0 | AstraZenecaINDUSTRY | 0 | Jan 29, 2013 | clinicaltrials |
| NCT01266811 | A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | withdrawn | Phase 3 | 0 | Centocor, Inc.INDUSTRY | 14 | Jan 28, 2013 | clinicaltrials |
| NCT00137358 | Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00227474 | S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Jan 24, 2013 | clinicaltrials |
| NCT01700010 | Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer | withdrawn | Phase 2 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00166647 | Thiopurine Methyltransferase Polymorphisms Evaluation | withdrawn | — | 0 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jan 11, 2013 | clinicaltrials |
| NCT00914043 | Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45 | withdrawn | — | 0 | NSABP Foundation IncNETWORK | 0 | Jan 11, 2013 | clinicaltrials |
| NCT01234974 | IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus | withdrawn | Phase 2 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 10, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 8, 2013source: clinicaltrials